Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China 2025-05-07 14:19
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
GP(HK) Enters into A Few Agreements in the Field of Cancer Diagnostics and Treatment 2020-11-02 17:01
1